Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) – Leading PAN India Manufacturer and Global Supplier

Taj Pharmaceuticals Ltd is a trusted manufacturer, supplier, and exporter of Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg, catering to the domestic PAN India market and international territories including Africa, the Middle East, and Latin America (LATAM). With WHO-GMP certified manufacturing facilities in Vapi, Gujarat, and Mumbai, Maharashtra, we specialize in delivering high-quality, affordable, and therapeutically effective antihypertensive medications for global healthcare markets.

Our Rilmenidine Dihydrogen Phosphate Tablets 1mg are widely recognized for safety, efficacy, and purity, making Taj Pharma a preferred partner for hospitals, distributors, and PCD Pharma Franchise networks across India and abroad.


About Rilmenidine Dihydrogen Phosphate Tablets (Cadrest)

Rilmenidine Dihydrogen Phosphate is a centrally acting antihypertensive agent classified as an imidazoline receptor agonist. It lowers blood pressure by reducing sympathetic nervous system activity, minimizing stress on the heart and blood vessels.

Key Features:

  • Effective for primary hypertension (high blood pressure)
  • Reduces the risk of cardiovascular events, including heart attack and stroke
  • Safe for long-term use with minimal side effects
  • Convenient oral administration once daily
  • Compatible for monotherapy or combination therapy

This medication is ideal for patients requiring long-term hypertension management and post-myocardial infarction care to enhance survival rates.


Rilmenidine Dihydrogen Phosphate Tablets – Therapeutic Benefits

Taj Pharma’s Rilmenidine Tablets 1mg offer a comprehensive approach to blood pressure management:

  1. Effective Hypertension Control
    • Rapidly reduces elevated blood pressure while minimizing the risk of sudden drops.
  2. Cardiovascular Risk Reduction
    • Lowers the risk of heart attacks and strokes in hypertensive patients.
  3. Post-Heart Attack Care
    • Enhances survival rates and heart function post-myocardial infarction.
  4. Long-Term Tolerability
    • Suitable for chronic administration, with minimal sedation and dizziness compared to older central agents.

Why Taj Pharmaceuticals Ltd is the #1 Manufacturer in India

1. Advanced Manufacturing Facilities

  • WHO-GMP and ISO certified plants in Vapi, Gujarat, and Mumbai, Maharashtra
  • State-of-the-art laboratories for quality control and stability testing
  • Compliance with international regulatory standards including US FDA, EU GMP, and MHRA (for specific export markets)

2. Global Export Capabilities

Our Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg are distributed across:

  • Africa: Kenya, Nigeria, Ghana, South Africa
  • Middle East: UAE, Saudi Arabia, Oman, Iraq
  • Latin America (LATAM): Peru, Chile, Mexico

We are pioneer exporters and PAN India suppliers, delivering bulk and finished formulations to government institutions, hospitals, and private markets.

3. Quality and Affordability

  • Stringent quality control at every stage of production
  • Therapeutically consistent batches for global patients
  • Competitive pricing for domestic and international markets

Dosage, Administration, and Precautions

Dosage:

  • Adult: 1mg once daily, preferably on an empty stomach
  • Adjustments may be required based on patient response and physician guidance

Administration:

  • Oral route, swallowed whole with water
  • Best results with long-term adherence to therapy

Precautions:

  • Avoid sudden discontinuation to prevent rebound hypertension
  • Use cautiously in severe renal impairment
  • Pregnant or breastfeeding women must consult a doctor before use
  • Report unusual fatigue, dizziness, or low blood pressure to a healthcare provider

Storage Guidelines

  • Temperature: Below 30°C
  • Environment: Cool, dry place, away from sunlight and moisture
  • Packaging: High-quality blister strips and secondary cartons to preserve stability
  • Safety: Keep out of reach of children

Technical Specifications of Rilmenidine Dihydrogen Phosphate Tablets

  • Product Name: Rilmenidine Dihydrogen Phosphate Tablets
  • Brand Name: Cadrest
  • Strength: 1mg
  • Dosage Form: Oral tablet
  • Route of Administration: Oral
  • Packing: 10 tablets per blister strip, 100 tablets per box
  • Regulatory Documents: WHO-GMP, COA, COPP, FSC (on request)
  • Therapeutic Use: Antihypertensive medication
  • Indications: Treatment of hypertension, cardiovascular risk reduction
  • Storage: Store below 30°C, in dry conditions
  • Dosage: As prescribed by a healthcare professional

PCD Pharma Franchise and Distribution Partnership

Taj Pharma offers lucrative PCD Pharma Franchise and distribution opportunities for Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg.

Benefits of partnering with Taj Pharma:

  • Exclusive territorial marketing rights
  • Timely product availability with robust logistics support
  • Marketing materials and promotional support for franchise partners
  • High-quality and competitively priced formulations

We ensure our franchise and distribution partners can expand their market presence while delivering trusted antihypertensive medications to healthcare providers and patients.


Rilmenidine Dihydrogen Phosphate Tablets 1mg Manufacturers PAN India Suppliers Exporters
Rilmenidine Dihydrogen Phosphate Tablets 1mg

Rilmenidine Dihydrogen Phosphate Tablets – PAN India & Export Supply

Taj Pharmaceuticals Ltd has established itself as the leading supplier of Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg in PAN India, including Mumbai, Delhi, Bangalore, Kolkata, Hyderabad, and Chennai.

Our international reach makes us a reliable global partner, fulfilling bulk, tender, and private market demands with unmatched consistency and quality assurance.


Contact Taj Pharmaceuticals Ltd

To source premium Rilmenidine Dihydrogen Phosphate Tablets (Cadrest) 1mg or inquire about PCD Pharma Franchise opportunities, connect with Taj Pharma today.

📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
Tel. No.: +91-22-2637 4592 / 4593
📠 Fax: +91-22-2634 1274